Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 12:36 pm Purchase |
2024-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
JANUS HENDERSON GROUP PLC JHG |
1,015,023 5.400% |
5,929![]() (+0.59%) |
Filing History |
2025-02-05 1:23 pm Sale |
2024-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
BLACKROCK INC BLK |
2,945,939 15.600% |
-16,155![]() (-0.55%) |
Filing History |
2024-11-14 3:19 pm Sale |
2024-09-30 | 13G | Ligand Pharmaceuticals Incorporated LGND |
JANUS HENDERSON GROUP PLC JHG |
1,009,094 5.500% |
-334,060![]() (-24.87%) |
Filing History |
2024-11-08 5:34 pm Sale |
2024-09-30 | 13G | Ligand Pharmaceuticals Incorporated LGND |
GOLDMAN SACHS GROUP INC GS |
52,350 0.300% |
-1,129,581![]() (-95.57%) |
Filing History |
2024-11-01 4:07 pm Sale |
2024-09-30 | 13G | Ligand Pharmaceuticals Incorporated LGND |
Macquarie Group Limited | 887,275 4.860% |
-99,973![]() (-10.13%) |
Filing History |
2024-02-14 06:26 am Sale |
2023-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
Macquarie Group Limited | 987,248 5.660% |
-14,577![]() (-1.46%) |
Filing History |
2024-02-13 5:08 pm Purchase |
2023-12-29 | 13G | Ligand Pharmaceuticals Incorporated LGND |
The Vanguard Group | 1,876,514 10.760% |
33,399![]() (+1.81%) |
Filing History |
2024-02-13 3:39 pm Purchase |
2023-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
JANUS HENDERSON GROUP PLC JHG |
1,343,154 7.700% |
87,881![]() (+7.00%) |
Filing History |
2024-02-12 7:42 pm Purchase |
2023-12-29 | 13G | Ligand Pharmaceuticals Incorporated LGND |
GOLDMAN SACHS GROUP INC GS |
1,181,931 6.800% |
1,181,931![]() (New Position) |
Filing History |
2024-01-22 2:03 pm Purchase |
2023-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
BLACKROCK INC BLK |
2,962,094 17.000% |
172,615![]() (+6.19%) |
Filing History |
2023-03-30 4:08 pm Sale |
2023-03-28 | 13D | Viking Therapeutics, Inc. VKTX |
LIGAND PHARMACEUTICALS INC LGND |
3,616,077 4.600% |
-2,449,003![]() (-40.38%) |
Filing History |
2023-02-10 3:23 pm Sale |
2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
JANUS HENDERSON GROUP PLC JHG |
1,255,273 7.400% |
-1,054,786![]() (-45.66%) |
Filing History |
2023-02-09 4:30 pm Sale |
2023-02-06 | 13D | Viking Therapeutics, Inc. VKTX |
LIGAND PHARMACEUTICALS INC LGND |
6,065,080 7.900% |
-1,274,303![]() (-17.36%) |
Filing History |
2023-02-09 1:53 pm Sale |
2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 141,128 0.800% |
-2,103,619![]() (-93.71%) |
Filing History |
2023-02-09 11:25 am Sale |
2022-12-30 | 13G | Ligand Pharmaceuticals Incorporated LGND |
The Vanguard Group | 1,843,115 10.910% |
-908,811![]() (-33.02%) |
Filing History |
2023-02-06 3:18 pm Sale |
2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
STATE STREET CORP STT |
649,914 3.850% |
-772,513![]() (-54.31%) |
Filing History |
2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
BLACKROCK INC BLK |
2,789,479 16.500% |
0 (Unchanged) |
Filing History |
2023-01-20 5:17 pm Sale |
2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
BLACKROCK INC BLK |
2,789,479 16.500% |
-1,607,242![]() (-36.56%) |
Filing History |
2022-02-14 10:39 am Sale |
2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
Macquarie Group Limited | 1,001,825 3.740% |
-462,760![]() (-31.60%) |
Filing History |
2022-02-11 6:20 pm Sale |
2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
CARDINAL CAPITAL MANAGEMENT LLC | 260,661 1.000% |
-1,483,828![]() (-85.06%) |
Filing History |